Pharmaceutical

Modella AI and AstraZeneca link for cancer clinical development

Modella AI has signed a multi-year agreement with AstraZeneca for expediting AI-driven oncology clinical development.

Jul 5, 2025 - 06:00
Modella AI and AstraZeneca link for cancer clinical development
Modella AI has signed a multi-year agreement with AstraZeneca for expediting AI-driven oncology clinical development.
Read the original article

Tags:

Previous Article

Five lessons from biopharma companies’ data transformation journeys

Next Article

AstraZeneca’s Imfinzi approved in Europe for muscle-invasive bladder cancer

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Grünenthal gains Valinor Pharma and constipation drug Movantik

Grünenthal gains Valinor Pharma and constipation drug M...

Jul 24, 2024

Opinion: STAT readers on Census data, nutrition education, and a better approach to epinephrine

Opinion: STAT readers on Census data, nutrition educati...

Jan 6, 2024

STAT+: Pharmalittle: Weight-loss drug makers lobby Congress for Medicare coverage; Europe braces for new pharma legislation

STAT+: Pharmalittle: Weight-loss drug makers lobby Cong...

Apr 25, 2023